Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. NC3802713

FOCUS BIOMOLECULES Biochemical Reagents, Mito-lonidamine, Mitochondria-targeted antiglycolytic agent, CAS 2361564-49-8, 98% by TLC/NMR (Conforms)
SDP

Catalog No. NC3802713
Encompass_Preferred

Biochemical Reagents, Mito-lonidamine, Mitochondria-targeted antiglycolytic agent, CAS 2361564-49-8, 98% by TLC/NMR (Conforms), Antiglycolytic drug with limited efficacy.1,2 Mito-lonidamine (2361564-49-8) is lonidamine conjugated to a triphenylphosphonium moiety via a decyl-linker which is an effective mitochondria-targeting group.3 Mito-lonidamine was shown to be100-fold more potent than lonidamine. It is a tumor-selective inhibitor of oxidative phosphorylation inhibiting mitochondrial bioenergetics in lung cancer cells and suppressing lung cancer cell viability, growth, progression and metastasis of lung cancer xenografts in mice.3

Catalog No. NC3802713 Supplier FOCUS BIOMOLECULES Supplier No. 10549225MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

Biochemical Reagents, Mito-lonidamine, Mitochondria-targeted antiglycolytic agent, CAS 2361564-49-8, 98% by TLC/NMR (Conforms), Antiglycolytic drug with limited efficacy.1,2 Mito-lonidamine (2361564-49-8) is lonidamine conjugated to a triphenylphosphonium moiety via a decyl-linker which is an effective mitochondria-targeting group.3 Mito-lonidamine was shown to be100-fold more potent than lonidamine. It is a tumor-selective inhibitor of oxidative phosphorylation inhibiting mitochondrial bioenergetics in lung cancer cells and suppressing lung cancer cell viability, growth, progression and metastasis of lung cancer xenografts in mice.3

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.